Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion

被引:20
作者
Erickson, KD [1 ]
Martin, JM [1 ]
机构
[1] UNIV COLORADO, DEPT MOL CELLULAR & DEV BIOL, BOULDER, CO 80309 USA
关键词
D O I
10.1006/viro.1997.8638
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Epstein-Barr virus (EBV)-positive B958 cell line expresses two related membrane proteins encoded by BNLF-1 open reading frames. One protein (LMP-1) has been shown to be essential for the growth transforming properties of EBV. The second protein (the lytic LMP-1) is an amino-terminally truncated form of LMP-I whose expression is associated with induction of EBV's lytic cycle. We have investigated the expression or full-length and lytic forms of LMP-I immediately after infection of the EBV-negative, a-lymphoma cell line BJAB. Only the lytic LMP-1 protein is present in BJAB cells early (within minutes following addition of virus) after infection with virus derived from either uninduced or tetradecanoyl phorbol acetate and sodium butyrate-induced B958 cells. Lytic LMP-1 protein levels begin to decline by 48 hr after infection, whereas levels of full-length LMP-1 increase between 24 and 48 hr after infection and then remain constant. The presence of the lytic LMP-1 protein in infected cells is independent of both protein synthesis and virus internalization. We also find the lytic LMP-I protein in BJAB cells early after infection (within 3 hr of addition of virus) with the HH514 strain of EBV, and HH514 cells treated with tetradecanoyl phorbol acetate and sodium butyrate, express high levels of both the lytic LMP-I and full-length LMP-1 proteins. The lytic LMP-1 protein is enriched in purified virion preparations, and immunoelectron microscopic analysis indicates that EBV virions can be specifically labeled with a nti-LM P-l antisera. Together, these results are consistent with a model in which the lytic LMP-1 protein is present in the EBV virion and is carried into the B-cell upon infection and suggest a role for this protein in early infection events and/or in EBV's lytic cycle. (C) 1997 Academic Press.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 41 条
[31]  
NEMEROW GR, 1981, J IMMUNOL, V127, P272
[32]   CELLULAR LOCALIZATION OF AN EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED COMPLEMENT-FIXING ANTIGEN IN PRODUCER AND NON-PRODUCER LYMPHOBLASTOID CELL LINES [J].
REEDMAN, BM ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1973, 11 (03) :499-520
[33]   3 PATHWAYS OF EPSTEIN-BARR-VIRUS GENE ACTIVATION FROM EBNA1-POSITIVE LATENCY IN LYMPHOCYTES-B [J].
ROWE, M ;
LEAR, AL ;
CROOMCARTER, D ;
DAVIES, AH ;
RICKINSON, AB .
JOURNAL OF VIROLOGY, 1992, 66 (01) :122-131
[34]  
ROWE M, 1987, J GEN VIROL
[35]   2 RELATED EPSTEIN-BARR VIRUS MEMBRANE-PROTEINS ARE ENCODED BY SEPARATE GENES [J].
SAMPLE, J ;
LIEBOWITZ, D ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1989, 63 (02) :933-937
[36]  
SINCLAIR AJ, 1996, J VIROL, V69, P5481
[37]   PROTEINS SPECIFIED BY HERPES-SIMPLEX VIRUS .5. PURIFICATION AND STRUCTURAL PROTEINS OF HERPESVIRION [J].
SPEAR, PG ;
ROIZMAN, B .
JOURNAL OF VIROLOGY, 1972, 9 (01) :143-+
[38]   EPSTEIN-BARR VIRUS LATENT INFECTION MEMBRANE-PROTEIN ALTERS THE HUMAN LYMPHOCYTE-B PHENOTYPE - DELETION OF THE AMINO TERMINUS ABOLISHES ACTIVITY [J].
WANG, D ;
LIEBOWITZ, D ;
WANG, F ;
GREGORY, C ;
RICKINSON, A ;
LARSON, R ;
SPRINGER, T ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1988, 62 (11) :4173-4184
[39]   THE TRUNCATED FORM OF THE EPSTEIN-BARR VIRUS LATENT-INFECTION MEMBRANE-PROTEIN EXPRESSED IN VIRUS-REPLICATION DOES NOT TRANSFORM RODENT FIBROBLASTS [J].
WANG, D ;
LIEBOWITZ, D ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1988, 62 (07) :2337-2346
[40]   EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN (LMP1) AND NUCLEAR PROTEIN-2 AND PROTEIN-3C ARE EFFECTORS OF PHENOTYPIC CHANGES IN LYMPHOCYTES-B - EBNA-2 AND LMP1 COOPERATIVELY INDUCED CD23 [J].
WANG, F ;
GREGORY, C ;
SAMPLE, C ;
ROWE, M ;
LIEBOWITZ, D ;
MURRAY, R ;
RICKINSON, A ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2309-2318